Genelabs Technologies, Inc. Reports Results for the First Quarter of 2008 and Progress on Operational Priorities

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB), a biopharmaceutical company focused on discovering novel compounds for hepatitis, reported first quarter financial results for 2008. The Company also provided an update on its 2008 operational priorities.
MORE ON THIS TOPIC